Stockreport

Hims & Hers Health: The GLP-1 Trade Just Got Real (Rating Downgrade) [Seeking Alpha]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF The FDA signaled new limits on non-approved compounded GLP-1 APIs being mass-marketed, and it explicitly called out Hims. Hims launched, then halted, an oral compound [Read more]